Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Amr Hanbali | Therapeutic use of Cellular therapy in cancer treatment | Best Researcher Award

Assoc. Prof. Dr. Amr Hanbali | King Faisal Specialist Hospital & Research Center | Saudi Arabia

Dr. Amr AlHanbali is a dual-certified Hematology and Oncology consultant with over 18 years of experience in malignant and benign hematological conditions. Based at King Faisal Specialist Hospital & Research Center in Riyadh, Saudi Arabia, he specializes in hematologic malignancies and stem cell transplantation. Dr. AlHanbali previously served as a senior staff physician and Associate Fellowship Program Director at Henry Ford Health System in Detroit, Michigan. Recognized for his academic involvement, he holds teaching appointments at Wayne State University and Alfaisal University. Known for his dedication to clinical mentorship, he has trained numerous medical students, residents, and fellows. He is actively involved in research and is a member of several prestigious medical organizations including the American Society of Hematology and American Society of Clinical Oncology. With expertise ranging from bone marrow procedures to managing complex hematologic disorders, Dr. AlHanbali is a respected leader in the field of hematology and stem cell transplantation.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Research Contribution

    • Over 17 peer-reviewed publications, including impactful case reports, national guidelines, and original research in hematology, oncology, and stem cell transplantation.

    • Active contributor to national guidelines on multiple myeloma, reflecting leadership in shaping national healthcare standards in KSA.

  2. Dual Academic and Clinical Roles

    • Combines academic excellence (as faculty at Wayne State University and Alfaisal University) with hands-on clinical expertise at a premier institution (King Faisal Specialist Hospital & Research Center).

  3. Innovative Focus in Hematology and Transplantation

    • Research into underexplored areas such as hepatitis B reactivation post-rituximab, genetic donor match outcomes, and therapies for AL amyloidosis.

  4. International Exposure and Leadership

    • Experience across the U.S. and Saudi Arabia, influencing programs in both systems.

    • Played a key role in training and selecting future hematology-oncology fellows in the U.S.

  5. Mentorship and Capacity Building

    • Mentored numerous trainees, enhancing research culture among younger clinicians.

Areas for Improvement:

  1. Higher Impact Publications Needed

    • While the volume and variety of research are commendable, more publications in top-tier journals (NEJM, Lancet, Blood, JCO) could boost citation impact and visibility.

  2. Research Grants and Collaborative Trials

    • Pursuing multicenter studies, international collaborations, or industry-sponsored clinical trials would further elevate his profile and expand research funding sources.

  3. Technological Innovation/Patents

    • Exploring biotech innovation, AI in diagnostics, or cellular therapy patents could position him among the top medical innovators.

Education:

Dr. Amr AlHanbali completed his Bachelor of Medicine and Surgery from the University of Jordan in 1999. He pursued medical training in the United States, starting with an internal medicine residency (2001–2004) at Henry Ford Health System, Detroit. He continued his specialization with a fellowship in Hematology and Oncology (2004–2007) at the same institution. During his training, he also undertook elective rotations in Pediatric Cardiology and Gastroenterology at the University of Texas Medical Branch, Galveston, further enriching his academic exposure. He is certified by the American Board of Internal Medicine in Internal Medicine (2004), Hematology (2007), and Oncology (2007). Dr. AlHanbali holds academic titles as a Clinical Assistant Professor at Wayne State University, Detroit, and Adjunct Associate Professor at Alfaisal University, Riyadh. His educational background reflects a strong foundation in internal medicine, with a deep focus on hematology and oncology, further supported by teaching and research excellence.

Experience:

Dr. AlHanbali’s clinical career spans over 18 years, currently serving as Hematology and Stem Cell Transplant Consultant at King Faisal Specialist Hospital & Research Center in Riyadh since 2013. Prior to this, he held multiple leadership roles at Henry Ford Health System, Detroit, including Senior Staff Physician and Associate Fellowship Program Director (2007–2013). His medical expertise covers the diagnosis and treatment of a wide range of hematologic malignancies such as leukemia, lymphoma, multiple myeloma, and myeloproliferative disorders. Dr. AlHanbali also has extensive experience in stem cell transplantation, intrathecal chemotherapy, and bone marrow biopsy. He has been instrumental in resident selection and curriculum development for fellowship programs in hematology and oncology. His work bridges clinical excellence with academic mentorship, guiding numerous trainees and junior physicians. In addition to patient care, he is involved in clinical guideline development and research, particularly in the field of multiple myeloma and transplant outcomes.

Research Focus:

Dr. Amr AlHanbali’s research is centered on hematologic malignancies, particularly multiple myeloma, lymphoma, leukemia, and stem cell transplantation. His work explores novel therapeutic approaches, transplant outcomes, disease progression, and treatment-related complications. He has contributed significantly to research on hepatitis B reactivation, chemotherapy-induced toxicities, and the protective role of comorbidities like diabetes in cancer metastasis. As an active member of the Saudi Myeloma Working Group, he has co-authored national guidelines for both newly diagnosed and relapsed/refractory multiple myeloma. His studies also examine health disparities in cancer care, including outcomes among African American populations and the impact of familial genetics in donor matches. With over a dozen peer-reviewed publications and case reports in high-impact journals, Dr. AlHanbali continues to push forward understanding in clinical hematology and oncology. He combines bedside insights with academic rigor to shape evidence-based practice and improve treatment outcomes in cancer and transplant medicine.

Publications Top Notes:

  1.  Mediastinal Hematoma With SVC Syndrome From A Central Venous Catheter Insertion – CHEST, 2003

  2.  Diabetes Has Protective Effect Against Metastasis in Non-Small Cell Lung Cancer – Arch Intern Med, 2007

  3.  Delayed Hepatitis B Viral Replication Post-Rituximab & Fludarabine in Waldenstrom Macroglobulinemia – Am J Hematol, 2007

  4.  Acute Pancreatitis Induced by Adult Precursor B-cell ALL – South Med J, 2007

  5.  Hypersensitivity Reaction of Mylotarg with Platelet Transfusion – Am J Health Syst Pharm, 2007

  6.  Incidence of Hepatitis B Reactivation after Rituximab Therapy – Am J Hematol, 2009

  7. Outcomes After Auto-SCT in African Americans with Multiple Myeloma – Bone Marrow Transplant, 2009

  8.  HER-2 Status May Change in Recurrent Breast Cancer – Cancer Research, 2009

  9.  Compartment Syndrome as Presentation of Chronic Myelogenous Leukemia – J Gen Intern Med, 2010

  10.  Use of Insulin and its Effect on Survival in NSCLC – J Clin Oncol, 2009

Conclusion:

Dr. Amr AlHanbali demonstrates a stellar blend of clinical expertise, research productivity, academic mentorship, and leadership in hematology and oncology. His research contributions have practical implications in areas such as multiple myeloma, leukemia, transplant immunology, and chemotherapy safety.

He is highly deserving of recognition and stands out as a top contender for a Best Researcher Award, particularly in the categories of clinical research excellence, translational hematology, and medical education integration with research.

ALICIA MARIA TAMAYO CARBON | Stem Cell Research | Women Researcher Award

Published on by Cell Biologist

Dr. ALICIA MARIA TAMAYO CARBON | Stem Cell Research | Women Researcher Award

Dr. ALICIA MARIA TAMAYO CARBON , HOSPITAL CLÍNICO QUIRÚRGICO HERMANOS AMEIJEIRAS , Cuba

Dra. C. Alicia María Tamayo Carbón is a highly accomplished specialist in plastic surgery and caumatology at the Hermanos Ameijeiras Clinical and Surgical Hospital in Cuba. With extensive academic and professional qualifications, she holds a medical degree, multiple specializations in comprehensive general medicine, plastic surgery, and caumatology, and is an expert in regenerative therapy. She is a researcher, professor, and author of numerous scientific papers and book chapters. Dra. Tamayo Carbón is recognized for her pioneering work in regenerative therapy using adipose tissue. She has received national recognition with awards like the National Impact Award from ANIR and the Meritorious Researcher Award from CIGB. Dra. Tamayo has collaborated with various institutions on groundbreaking research in regenerative medicine and gender reassignment. She is a prominent member of several professional organizations, contributing significantly to medical advancements in Cuba and beyond.

Publication Profile: 

Orcid

Strengths for the Award:

Dra. Alicia María Tamayo Carbón is an outstanding candidate for the Women Researcher Award due to her extensive contributions to the fields of plastic surgery, caumatology, and regenerative therapy. Her pioneering work in adipose tissue-based regenerative therapy has had a profound impact on the medical community, both nationally and internationally. With 11 ongoing research projects, 125 published journals, and significant collaborations with renowned institutions, her academic and clinical achievements have earned her multiple accolades such as the National Impact Award and Meritorious Researcher Award. Additionally, her leadership roles in scientific councils and her involvement in various groundbreaking projects highlight her influence and dedication to advancing medical practices, particularly in cosmetic and reconstructive surgery, as well as in gender reassignment. Her contributions have also led to the publication of books, patents, and a strong academic presence.

Areas for Improvement:

While Dra. Tamayo’s work is extensive and impactful, expanding her visibility in international collaborations outside of Cuba and increasing her citation index could enhance her global recognition. Further engagement in multidisciplinary collaborations, particularly in the areas of advanced technologies like AI or machine learning in surgery, could be explored to push the boundaries of her work in regenerative therapy.

Education:

Dra. Alicia María Tamayo Carbón’s academic journey reflects her dedication to advancing medical knowledge and practice. She began with a medical degree, followed by first-degree specialization in comprehensive general medicine. Her pursuit of excellence continued as she achieved both first- and second-degree specialization in plastic surgery and caumatology. Additionally, she holds a diploma in healthcare management and a university postgraduate degree in aesthetic medicine from the University of the Atlantic, Barcelona, Spain. Her academic foundation is complemented by a specialization in regenerative therapy, reinforcing her commitment to innovative treatments in her field. Dra. Tamayo Carbón’s academic achievements are paired with a passion for teaching, as she serves as a professor for the Master’s program in Aesthetic Medicine in Barcelona. Her educational path has laid the groundwork for her contributions to regenerative therapy and aesthetic medicine, making her a recognized expert in her field.

Experience:

Dra. Alicia María Tamayo Carbón boasts a rich professional background in plastic surgery and regenerative therapy. As a full professor and researcher, she has significantly contributed to the field of regenerative therapy, particularly in the use of adipose tissue for medical treatments. Her extensive experience is underscored by her clinical work at the Hermanos Ameijeiras Clinical and Surgical Hospital in Cuba. Dra. Tamayo has also held pivotal roles in national and international collaborations, including projects with the Cuban Institute of Hematology and Immunology and CEADEN, focusing on stem cell research and tissue engineering. She has been a key figure in developing regenerative therapy applications for skin disorders, gender reassignment, and reconstructive surgery. Her leadership as the head of the national specialty group and her board membership in the Cuban Society of Plastic Surgery and Caumatology further highlight her influence. Dra. Tamayo’s professional career is marked by continuous advancements in surgical and therapeutic techniques.

Research Focus:

Dra. Alicia María Tamayo Carbón’s research focus lies at the intersection of plastic surgery, regenerative medicine, and tissue engineering. Her groundbreaking work in regenerative therapy, particularly the use of adipose tissue and stem cells for medical treatments, has positioned her as a leader in this field. She has led numerous projects that explore adipose-derived stem cells, nanofat, and tissue engineering, particularly in reconstructive surgery, cosmetic procedures, and gender reassignment. Dra. Tamayo has collaborated with several national and international institutions to explore the phenotypic characterization of stem cells and their application in regenerative therapies. Her work also includes investigating new methods in tissue engineering, such as 3D bioprinting of biodegradable scaffolds for regenerative purposes. She has actively contributed to the development of clinical trials targeting stem cells from umbilical cord adipose tissue. Through her research, Dra. Tamayo Carbón aims to improve patient outcomes and advance the field of regenerative therapy in aesthetic and reconstructive surgery.

Publications Top Notes:

  1. “Utilidad del tejido adiposo en el tratamiento de las deformidades mentonianas. Un rescate de la lipotransferencia” 🦷💉
  2. “Identificación y caracterización de células madre hematopoyéticas en tejido adiposo obtenidas por nanograsa” 🧬🔬
  3. “Masculinización torácica aplicada al tratamiento de la ginecomastia grave” 💪🏽👨‍⚕️
  4. “Restauración volumétrica autóloga en pacientes con hemiatrofia adiposa facial” 🤲🏽💉
  5. “Mastoplastia de aumento, complemento indispensable de feminización en trastornos de identidad de género” 🌸🏥
  6. “Aplicación del protocolo de recuperación posquirúrgica mejorada en la liposucción abdominal” 💪🏼🛏️
  7. “Nanofat, su expansión en la asistencia médica” 🧴⚙️
  8. “Reconstrucción mamaria con colgajo dérmico en cirugía de lesión benigna con alto riesgo de malignidad” 💕🏥
  9. “Activation of the Immune System by Irresponsible use of Modeling Substances” 🦠⚠️
  10. “Tratamiento quirúrgico periorbitario, un enfoque desde la cirugía plástica” 👁️💉

Conclusion:

Dra. C. Alicia María Tamayo Carbón is an exemplary figure in the medical field, particularly in regenerative medicine and plastic surgery. Her groundbreaking research and continuous efforts to improve patient outcomes through innovative therapies make her a deserving candidate for the Research for Women Researcher Award. Her contributions have not only advanced scientific knowledge but also positively impacted clinical practices, demonstrating her exceptional commitment to both research and education. Dra. Tamayo’s expertise, leadership, and sustained contributions solidify her as a leader and an inspiration for future generations of female researchers.